GABELLI FUNDS LLC - AUSPEX PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
GABELLI FUNDS LLC ownership history of AUSPEX PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2015$6,949,00069,3000.04%
Other shareholders
AUSPEX PHARMACEUTICALS INC shareholders Q2 2015
NameSharesValueWeighting ↓
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,984,038$44,185,0001.78%
Cormorant Asset Management, LP 100,000$2,227,0000.59%
WALL STREET ASSOCIATES 225,000$5,011,0000.43%
KINGDON CAPITAL MANAGEMENT, L.L.C. 304,076$6,772,0000.26%
KNOTT DAVID M 35,366$787,601,0000.14%
DRIEHAUS CAPITAL MANAGEMENT LLC 116,028$2,584,0000.08%
Visium Asset Management, LP 183,625$4,089,0000.06%
SHEPHERD KAPLAN KROCHUK, LLC 25,369$565,0000.06%
SABBY MANAGEMENT, LLC 50,000$1,114,0000.05%
MILLENNIUM MANAGEMENT LLC 661,361$14,729,0000.04%
View complete list of AUSPEX PHARMACEUTICALS INC shareholders